Geron (GERN) Other financing activities (2018 - 2024)
Geron's (GERN) quarterly Other financing activities came in at $6.0 million in Q4 2024, up 67.33% year-on-year from $3.6 million in Q1 2024, and up 67.52% quarter-over-quarter from $3.6 million in Q3 2024.
Geron (GERN) Other financing activities (2018 - 2024) Analysis & Trends
Geron has disclosed Other financing activities across 7 years of filings, most recently posting $6.0 million for Q4 2024.
- Other financing activities for Q4 2024 came in at $6.0 million, up 67.33% year-over-year; the trailing twelve-month figure through Dec 2024 was $32.7 million (up 150.06% YoY), and the FY2024 annual result was $32.7 million, up 150.06% from the prior year.
- Other financing activities came in at $6.0 million for Q4 2024 at Geron, up from $3.6 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $16.4 million in Q2 2024 to a low of $15000.0 in Q3 2020.
- The 5-year median for Other financing activities is $1.2 million (2022), against an average of $3.3 million.
- Across the five-year window, Other financing activities plunged 42.25% in 2020 and soared 2757.42% in 2024, its largest moves.
- Geron's Other financing activities stood at $15000.0 in 2020, then soared by 1146.67% to $187000.0 in 2021, then soared by 974.87% to $2.0 million in 2022, then surged by 78.01% to $3.6 million in 2023, then soared by 67.33% to $6.0 million in 2024.
- The last three Other financing activities figures came in at $6.0 million (Q4 2024), $3.6 million (Q3 2024), and $16.4 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Geron | 753,046.88 | 753,046.88 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.99 Mn |
| Dec 31, 2024 | 5.99 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Jun 30, 2024 | 16.37 Mn |
| Jun 30, 2024 | 16.37 Mn |
| Mar 31, 2024 | 6.75 Mn |
| Mar 31, 2024 | 6.75 Mn |
| Dec 31, 2023 | 3.58 Mn |
| Dec 31, 2023 | 3.58 Mn |
| Sep 30, 2023 | 1.04 Mn |
| Sep 30, 2023 | 1.04 Mn |
| Jun 30, 2023 | 573,000.00 |
| Jun 30, 2023 | 573,000.00 |
| Mar 31, 2023 | 7.88 Mn |
| Mar 31, 2023 | 7.88 Mn |
| Dec 31, 2022 | 2.01 Mn |
| Dec 31, 2022 | 2.01 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Sep 30, 2022 | 1.20 Mn |